A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

Clinical trial NCT03814200 · COMPLETED

Trial details

NCT number: NCT03814200
Sponsor: Viatris Innovation GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2019-01-03
Primary completion: 2019-02-12
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.